Literature DB >> 17081696

Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N-methyl-D-aspartate receptors.

J Torres-Peraza1, S Pezzi, J M Canals, N Gavaldà, J M García-Martínez, E Pérez-Navarro, J Alberch.   

Abstract

The striatum is one of the brain areas most vulnerable to excitotoxicity, a lesion that can be prevented by neurotrophins. In the present study, intrastriatal injection of the N-methyl-d-aspartate receptor (NMDAR) agonist quinolinate (QUIN) was performed in mice heterozygous for neurotrophin-3 (NT3 +/-) or brain-derived neurotrophic factor (BDNF +/-) to analyze the role of endogenous neurotrophins on the regulation of striatal neurons susceptibility to excitotoxic injury. QUIN injection induced a decrease in dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa (DARPP-32) protein levels that was higher in NT-3 +/- than in BDNF+/- or wild type animals. This enhanced susceptibility was specific for enkephalin- and tachykinin-positive projection neurons, and also for parvalbumin-positive interneurons. However the excitotoxic damage in large interneurons was not modified in NT-3 +/- mice compared with wild type animals. This effect can be related to the regulation of NMDARs by endogenous NT-3. Thus, our results show that there is an age-dependent regulation of NMDAR subunits NR1 and NR2A, but not NR2B, in NT-3 +/- mice. The deficit of endogenous NT-3 induced a decrease in NR1 and NR2A subunits at postnatal day (P) 0 and P3 mice respectively, whereas an upregulation was observed in 12 week old NT-3 +/- mice. This differential effect was also observed after administration of exogenous NT-3. In primary striatal cultures, NT-3 treatment induced an enhancement in NR2A, but not NR2B, protein levels. However, intrastriatal grafting of NT-3 secreting-cells in adult wild type mice produced a down-regulation of NR2A subunit. In conclusion, NT-3 regulates the expression of NMDAR subunits modifying striatal neuronal properties that confers the differential vulnerability to excitotoxicity in projection neurons and interneurons in the striatum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081696     DOI: 10.1016/j.neuroscience.2006.09.038

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain.

Authors:  Padmesh S Rajput; Geetanjali Kharmate; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2011-11-25       Impact factor: 3.444

Review 2.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

3.  Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Brain Res Bull       Date:  2008-02-01       Impact factor: 4.077

4.  Neurotrophin-3 restores synaptic plasticity in the striatum of a mouse model of Huntington's disease.

Authors:  Victor G Gómez-Pineda; Francisco M Torres-Cruz; César I Vivar-Cortés; Elizabeth Hernández-Echeagaray
Journal:  CNS Neurosci Ther       Date:  2018-02-17       Impact factor: 5.243

5.  Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice.

Authors:  Padmesh S Rajput; Geetanjali Kharmate; Michael Norman; Shi-He Liu; Bhagavatula R Sastry; Charles F Brunicardi; Ujendra Kumar
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

6.  Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.

Authors:  Albert Giralt; Olga Carretón; Cristina Lao-Peregrin; Eduardo D Martín; Jordi Alberch
Journal:  Mol Neurodegener       Date:  2011-10-10       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.